Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cancer risk in carriers of TP53 germline variants grouped into different functional categories.
Müntnich LJ, Dutzmann CM, Großhennig A, Härter V, Keymling M, Mastronuzzi A, Montellier E, Nees J, Palmaers NE, Penkert J, Pfister SM, Ripperger T, Schott S, Silchmüller F, Hainaut P, Kratz CP. Müntnich LJ, et al. Among authors: grosshennig a. JNCI Cancer Spectr. 2025 Jan 28:pkaf008. doi: 10.1093/jncics/pkaf008. Online ahead of print. JNCI Cancer Spectr. 2025. PMID: 39873732
The Effect of Nabiximols on Driving Ability in Adults with Chronic Tic Disorders: Results of a Substudy Analysis of the Double-Blind, Randomized, Placebo-Controlled CANNA-TICS Trial.
Müller-Vahl KR, Pisarenko A, Ringlstetter R, Cimpianu CL, Fremer C, Weidinger E, Jenz EB, Musil R, Brunnauer A, Großhennig A. Müller-Vahl KR, et al. Among authors: grosshennig a. Cannabis Cannabinoid Res. 2024 Oct;9(5):1349-1359. doi: 10.1089/can.2023.0114. Epub 2024 Jan 23. Cannabis Cannabinoid Res. 2024. PMID: 38265476 Clinical Trial.
83 results